Loading viewer...
earnings
Format: PDF earnings
Ginkgo Bioworks' Q1 2024 business review covering operational updates, financial outlook, and strategic initiatives including site consolidation and workforce adjustments. The presentation details progress toward adjusted EBITDA breakeven, Biofab1 opening timeline, and expansion of biodefense capabilities through the bioradar network and AI tools development.
earnings
21 Pages
ΤΙΤΑΝ
Xiaomi Q2 2022 Earnings Presentation
earningsearnings
44 Pages
Xiaomi Corporation